Clinical Site 22 — Springfield, Massachusetts

Clinical Site 22 is a clinical research site located in Springfield, Massachusetts, United States 01107.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

Clinical Site 22 has participated in 1 clinical trials.

Therapeutic areas: Diabetic Retinopathy, Diabetic Macular Edema, NPDR - Non Proliferative Diabetic Retinopathy.

Sponsors: Ocuphire Pharma, Inc..

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Clinical Site 22?

Clinical Site 22 has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Clinical Site 22 conducted?

Clinical Site 22 has 1 clinical trials on record. Their work covers Diabetic Retinopathy, Diabetic Macular Edema, NPDR - Non Proliferative Diabetic Retinopathy.

Is Clinical Site 22 accredited by Crixeo Health?

Clinical Site 22 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Clinical Site 22?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.